Open company graph database — free web & API
Login

Astellas Pharma EOOD

Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
0
§01

Basic information

BASIC
Head office
Tokyo
Chief executive
Okamura
Capital
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

4
Products and Disease AreasRx+ Business CreationImprovement of Astellas Products AccessibilitySustainability in Business Activities
§04

Related companies

0 COMPANIES

—

§05

Network

NETWORK
Drag to move · click to open
§06

History

8 EVENTS

Fujisawa Pharmaceutical was established in 1894Sources

Yamanouchi Pharmaceutical was established in 1923Sources

Yamanouchi Pharmaceutical changed its name to Yamanouchi Pharmaceutical Co., Ltd. in 1940Sources

Yamanouchi Pharmaceutical relocated its headquarters to Tokyo in 1942Sources

Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy.Sources

Leaders from Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical shook hands, commemorating the 2005 merger that led to the founding of Astellas. This merger shaped a global strategy centered on patients.Sources

Astellas Pharma celebrated its 20th anniversary in April 2025.Sources

In April 2025, Astellas celebrated our 20th anniversary as a company. Astellas was established in April 2005 through the merger of two companies – Yamanouchi Pharmaceutical (founded in 1923) and Fujisawa Pharmaceutical (founded in 1894). The merger brought together Yamanouchi's strengths in urological medications and chemical synthesis and Fujisawa's excellence in the transplant/immunology area and fermentation technology, forming an ideal complementary partnership.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑